Moderna (MRNA) Short Interest Ratio & Short Volume $39.63 +0.07 (+0.18%) (As of 09:04 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Moderna Short Interest DataModerna (MRNA) has a short interest of 40.84 million shares, representing 11.90% of the float (the number of shares available for trading by the public). This marks a 2.46% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.6, indicating that it would take 5.6 days of the average trading volume of 5.12 million shares to cover all short positions.Current Short Interest40,840,000 sharesPrevious Short Interest39,860,000 sharesChange Vs. Previous Month+2.46%Dollar Volume Sold Short$1.76 billionShort Interest Ratio5.6 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares384,818,000 sharesFloat Size343,140,000 sharesShort Percent of Float11.90%Today's Trading Volume42,558 sharesAverage Trading Volume5,123,313 sharesToday's Volume Vs. Average1% Short Selling Moderna? Sign up to receive the latest short interest report for Moderna and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRNA Short Interest Over TimeMRNA Days to Cover Over TimeMRNA Percentage of Float Shorted Over Time Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Moderna Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202440,840,000 shares $1.76 billion +2.5%11.9%5.6 $43.06 11/15/202439,860,000 shares $1.47 billion +15.9%11.6%5.8 $36.85 10/31/202434,380,000 shares $1.87 billion +3.4%10.0%6.3 $54.36 10/15/202433,260,000 shares $1.91 billion +6.2%9.7%6.7 $57.31 9/30/202431,320,000 shares $2.09 billion +13.4%9.1%6.6 $66.83 9/15/202427,610,000 shares $1.89 billion +7.7%8.1%6.1 $68.28 Get the Latest News and Ratings for MRNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moderna and its competitors with MarketBeat's FREE daily newsletter. 8/31/202425,630,000 shares $1.98 billion +2.5%7.5%6.7 $77.40 8/15/202425,000,000 shares $2.17 billion +10.7%7.3%6 $86.62 7/31/202422,590,000 shares $2.69 billion -0.7%6.7%5.4 $119.22 7/15/202422,740,000 shares $2.76 billion +2.8%6.8%5.8 $121.48 6/30/202422,130,000 shares $2.63 billion +2.5%6.6%5.6 $118.75 6/15/202421,600,000 shares $3.02 billion +7.0%6.4%5.5 $140.03 5/31/202420,180,000 shares $2.88 billion -5.8%6.0%4.9 $142.55 5/15/202421,430,000 shares $2.77 billion +1.7%6.4%5.4 $129.06 4/30/202421,070,000 shares $2.32 billion +0.4%6.3%5.4 $110.31 4/15/202420,980,000 shares $2.18 billion -2.2%6.2%5.6 $103.86 3/31/202421,440,000 shares $2.28 billion -3.6%6.4%5.2 $106.56 3/15/202422,230,000 shares $2.31 billion +0.5%6.6%5 $103.85 2/29/202422,110,000 shares $2.04 billion -8.2%6.6%4.4 $92.24 2/15/202424,080,000 shares $2.19 billion +15.3%7.2%5 $91.14 1/31/202420,880,000 shares $2.11 billion -9.5%6.3%4.5 $101.05 1/15/202423,070,000 shares $2.44 billion -4.6%7.0%4.5 $105.95 12/31/202324,190,000 shares $2.41 billion +10.6%7.3%4.6 $99.45 12/15/202321,880,000 shares $1.88 billion -0.5%6.6%4.7 $86.01 11/30/202321,990,000 shares $1.71 billion -1.7%6.6%5.4 $77.70 11/15/202322,380,000 shares $1.71 billion +14.1%6.8%5.6 $76.35 10/31/202319,610,000 shares $1.49 billion +8.6%5.9%4.6 $75.96 10/15/202318,050,000 shares $1.77 billion -2.3%5.5%4.5 $98.30 9/30/202318,470,000 shares $1.91 billion +1.7%5.6%4.9 $103.29 9/15/202318,160,000 shares $2.08 billion +0.6%5.5%4.8 $114.59 8/31/202318,050,000 shares $2.04 billion +4.8%5.5%5.1 $113.07 8/15/202317,220,000 shares $1.66 billion +9.2%5.2%4.6 $96.41 7/31/202315,770,000 shares $1.86 billion +1.7%4.8%4.6 $117.66 7/15/202315,510,000 shares $1.88 billion -11.7%4.7%4.8 $121.35 6/30/202317,560,000 shares $2.13 billion -4.2%5.3%5.2 $121.50 6/15/202318,320,000 shares $2.38 billion -2.1%5.5%5.5 $129.98 5/31/202318,720,000 shares $2.39 billion +2.7%5.6%5.6 $127.71 5/15/202318,220,000 shares $2.37 billion +2.1%5.5%5.1 $130.26 4/30/202317,850,000 shares $2.37 billion +6.9%5.4%5.1 $132.89 4/15/202316,700,000 shares $2.62 billion -2.6%5.0%4.7 $157.10How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 3/31/202317,150,000 shares $2.63 billion +7.9%5.1%4.8 $153.58 3/15/202315,890,000 shares $2.38 billion +1.3%4.7%4 $149.60 2/28/202315,680,000 shares $2.18 billion +6.9%4.7%3.2 $138.81 2/15/202314,670,000 shares $2.60 billion +3.8%4.4%3 $177.28 1/31/202314,130,000 shares $2.49 billion +0.6%4.2%2.9 $176.06 1/15/202314,040,000 shares $2.70 billion No Change4.2%2.7 $192.00 12/30/202214,040,000 shares $2.52 billion -15.8%4.2%2.6 $179.62 12/15/202216,670,000 shares $3.45 billion No Change5.0%3.1 $207.25 11/30/202216,670,000 shares $2.93 billion +4.3%5.0%3.6 $175.91 11/15/202215,980,000 shares $2.96 billion -3.0%4.8%3.3 $185.47 10/31/202216,480,000 shares $2.48 billion +2.0%5.0%3.3 $150.33 10/15/202216,160,000 shares $2.17 billion +2.2%4.8%3.3 $134.00 9/30/202215,810,000 shares $1.87 billion -3.2%4.7%3.5 $118.25 9/15/202216,340,000 shares $2.22 billion +7.4%4.9%3.3 $135.86 8/31/202215,210,000 shares $2.01 billion +1.5%4.5%3.1 $132.27 8/15/202214,980,000 shares $2.65 billion +1.7%4.4%2.9 $176.78 7/31/202214,730,000 shares $2.42 billion -9.6%4.3%2.7 $164.09 7/15/202216,290,000 shares $2.72 billion +14.3%4.8%2.9 $166.91 6/30/202214,250,000 shares $2.04 billion -3.5%4.2%2.4 $142.85 6/15/202214,760,000 shares $1.90 billion -4.9%4.3%2.4 $128.53 5/31/202215,520,000 shares $2.26 billion -9.0%4.5%2.3 $145.33 5/15/202217,060,000 shares $2.35 billion +10.6%5.0%2.4 $137.91 4/30/202215,430,000 shares $2.07 billion -3.6%4.4%2.1 $134.41 4/15/202216,010,000 shares $2.65 billion -1.2%4.6%2.2 $165.49 3/31/202216,210,000 shares $2.79 billion -6.1%4.7%2 $172.26 3/15/202217,260,000 shares $2.56 billion -2.0%5.0%1.9 $148.12 2/28/202217,610,000 shares $2.70 billion +7.0%5.1%2 $153.60 2/15/202216,460,000 shares $2.49 billion +2.7%4.7%1.6 $151.12 1/31/202216,030,000 shares $2.71 billion +1.5%4.6%1.5 $169.33 1/15/202215,800,000 shares $3.23 billion -5.3%4.5%1.3 $204.73 12/31/202116,690,000 shares $4.24 billion +8.7%4.8%1.4 $253.98 12/15/202115,360,000 shares $4.35 billion +0.5%4.4%1.2 $283.28 11/30/202115,290,000 shares $5.39 billion +4.9%4.4%1.1 $352.43 11/15/202114,570,000 shares $3.42 billion +12.0%4.2%1.2 $235.07 10/29/202113,010,000 shares $4.49 billion -12.1%3.8%0.9 $345.21 10/15/202114,800,000 shares $4.80 billion +3.3%4.3%0.9 $324.21 9/30/202114,330,000 shares $5.52 billion +0.2%4.2%0.7 $384.86 9/15/202114,300,000 shares $6.21 billion +3.9%4.2%0.8 $434.46 8/31/202113,770,000 shares $5.19 billion -10.6%4.0%0.8 $376.69 8/13/202115,400,000 shares $6.00 billion -18.1%4.5%0.9 $389.78 7/30/202118,810,000 shares $6.65 billion +37.8%5.5%1.3 $353.60 7/15/202113,650,000 shares $3.54 billion +9.6%4.0%1.1 $259.68 6/30/202112,460,000 shares $2.93 billion -13.1%3.6%1.3 $234.98 6/15/202114,330,000 shares $2.89 billion +21.1%4.2%1.5 $201.59 5/28/202111,830,000 shares $2.19 billion -1.0%3.5%1.3 $185.01 5/14/202111,950,000 shares $1.79 billion -7.7%N/A1.3 $149.87 4/30/202112,940,000 shares $2.27 billion +9.3%N/A1.3 $175.67 4/15/202111,840,000 shares $1.89 billion -8.6%N/A1.1 $160.03 3/31/202112,950,000 shares $1.53 billion -13.5%N/A1.1 $118.49 3/15/202114,970,000 shares $2.05 billion +12.6%N/A1 $136.99How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 2/26/202113,290,000 shares $1.97 billion -9.5%N/A0.7 $148.38 2/12/202114,690,000 shares $2.69 billion -26.5%4.5%0.6 $183.44 1/29/202119,980,000 shares $3.19 billion -19.4%6.1%0.8 $159.55 1/15/202124,800,000 shares $3.22 billion +6.0%7.6%1.1 $129.72 12/31/202023,390,000 shares $2.60 billion -8.6%7.2%1.1 $111.13 12/15/202025,580,000 shares $3.97 billion -7.5%7.9%1.3 $155.07 11/30/202027,640,000 shares $3.51 billion +12.0%8.5%1.7 $127.03 11/15/202024,680,000 shares $2.21 billion -2.2%7.6%2.3 $89.39 10/30/202025,230,000 shares $1.80 billion -7.7%7.8%2.7 $71.28 10/15/202027,340,000 shares $2.09 billion -9.6%8.5%2.4 $76.56 9/30/202030,250,000 shares $2.14 billion +7.2%9.4%1.7 $70.75 9/15/202028,220,000 shares $1.89 billion +0.7%8.8%1.4 $66.88 8/31/202028,020,000 shares $1.82 billion -11.5%8.7%1.4 $64.89 8/14/202031,660,000 shares $2.19 billion +16.4%9.9%1.4 $69.15 7/31/202027,190,000 shares $2.01 billion +10.0%8.7%1 $74.10 7/15/202024,710,000 shares $1.98 billion -13.7%8.0%1 $80.22 6/30/202028,640,000 shares $1.84 billion -0.4%9.7%1.4 $64.21 6/15/202028,760,000 shares $1.91 billion +25.8%9.8%1.4 $66.57 5/29/202022,860,000 shares $1.41 billion +14.4%8.3%1.1 $61.50 5/15/202019,980,000 shares $1.33 billion -10.0%8.5%0.9 $66.69 4/30/202022,200,000 shares $1.02 billion -7.0%11.1%1.2 $45.99 4/15/202023,880,000 shares $889.53 million +0.9%12.0%1.5 $37.25 3/31/202023,660,000 shares $1.19 billion +10.9%11.9%1.8 $50.50 3/13/202021,327,300 shares $679.49 million +5.8%9.5%1.4 $31.86 2/28/202020,150,000 shares $535.39 million +17.6%8.9%2.3 $26.57 2/14/202017,130,000 shares $382.68 million -8.6%7.8%3.1 $22.34 1/31/202018,750,000 shares $546.75 million -7.0%9.3%7 $29.16 1/15/202020,160,000 shares $430.42 million +6.2%10.0%9.6 $21.35 12/31/201918,990,000 shares $401.07 million +29.9%9.4%11.8 $21.12 MRNA Short Interest - Frequently Asked Questions What is Moderna's current short interest? Short interest is the volume of Moderna shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 40,840,000 shares of MRNA short. 11.90% of Moderna's shares are currently sold short. Learn More on Moderna's current short interest. What is a good short interest ratio for Moderna? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRNA shares currently have a short interest ratio of 6.0. Learn More on Moderna's short interest ratio. Which institutional investors are shorting Moderna? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Moderna: CTC LLC, Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., HighTower Advisors LLC, Centiva Capital LP, Garda Capital Partners LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, Crawford Fund Management LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, One River Asset Management LLC, LMR Partners LLP, Marathon Trading Investment Management LLC, Caas Capital Management LP, IMC Chicago LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Moderna? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.90% of Moderna's floating shares are currently sold short. Is Moderna's short interest increasing or decreasing? Moderna saw a increase in short interest in November. As of November 30th, there was short interest totaling 40,840,000 shares, an increase of 2.5% from the previous total of 39,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Moderna's float size? Moderna currently has issued a total of 384,818,000 shares. Some of Moderna's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Moderna currently has a public float of 343,140,000 shares. How does Moderna's short interest compare to its competitors? 11.90% of Moderna's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Moderna: Takeda Pharmaceutical Company Limited (0.15%), BioNTech SE (0.99%), Teva Pharmaceutical Industries Limited (1.98%), BeiGene, Ltd. (1.36%), Viatris Inc. (1.78%), Summit Therapeutics Inc. (2.28%), Genmab A/S (0.32%), Dr. Reddy's Laboratories Limited (1.32%), Sarepta Therapeutics, Inc. (6.09%), Catalent, Inc. (8.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Moderna stock? Short selling MRNA is an investing strategy that aims to generate trading profit from Moderna as its price is falling. MRNA shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Moderna? A short squeeze for Moderna occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MRNA, which in turn drives the price of the stock up even further. How often is Moderna's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRNA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Takeda Pharmaceutical Short Interest BioNTech Short Interest Teva Pharmaceutical Industries Short Interest BeiGene Short Interest Viatris Short Interest Summit Therapeutics Short Interest Genmab A/S Short Interest Dr. Reddy's Laboratories Short Interest Sarepta Therapeutics Short Interest Catalent Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRNA) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRNA Stock Alerts